Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

Please verify your email address. With the unveiling of the PS5 Pro came the reveal that Final Fantasy 7 Rebirth would be enhanced, suggesting big things for the third game. Would Square Enix ...

Roche's Genentech division has formed an R&D partnership with Arsenal Biosciences focusing on developing and refining the biotech's programmable T cell-based therapies platform. Genentech is ...

Square Enix producer Yoshinori Kitase promised fans of the original Final Fantasy 7 that they won’t feel betrayed by FF7 Remake Part 3. Kitase made the comments to Anime News Network in response ...

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.

Roche Holding AG said it isn’t concerned about side effects in a small study of a weight-loss shot, after details about the trial sent shares tumbling on Monday. “We’re not alarmed at all ...

FRANKFURT, Sept 11 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday the promising results of an early-stage trial of its experimental weight-loss pill that bolstered its shares in July ...

Shares of Roche Holding AG fell after a poster highlighted side effects in an early-stage study of the Swiss pharmaceutical company’s experimental obesity medicine. The poster, released as part ...

Preorders are now live for Final Fantasy 7 Remake: Material Ultimania Plus, a hardcover encyclopedic art book centered on the PS5 and PC version of Final Fantasy 7 Remake Intergrade. A sequel to ...

Final Fantasy 14 director Naoki "Yoshi-P" Yoshida outlined what's coming up on Patch 7.1 in his latest Letter from the Producer Live event at Tokyo Game Show overnight, including new artwork ...